Both in Pharmaceuticals
Johnson & Johnson vs ABBVIE
Over the past year JNJ returned +49.7% and ABBV returned +19.3%; their daily moves had a correlation of 0.49.
JNJ +49.7% ABBV +19.3%Growth of $1, one year, split-adjusted
| Metric | JNJ | ABBV |
|---|---|---|
| Price | $271.95 | $266.28 |
| Market cap | $655.37B | $470.55B |
| Today | +0.27% | +0.73% |
| 1 month | +2.3% | +3.1% |
| 6 months | +13.1% | +27.2% |
| Year to date | +31.4% | +16.5% |
| 1 year | +53.0% | +21.8% |
| Revenue growth (YoY) | +6.6% | +10.2% |
| Gross margin | 68.2% | 74.7% |
| Net margin | 21.9% | 21.3% |
| P/E (TTM) | 31.2× | 74.8× |
| Price / sales | 6.7× | 7.3× |
| Net cash | -$28.28B | -$64.25B |
| Dividend yield | 1.97% | 2.60% |
| Volatility (60d) | 20.7% | 21.8% |
| Short % of float | 0.9% | 1.1% |
| Next earnings | Oct 13, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).